David DiLillo
Company: Regeneron Pharmaceuticals
Job title: Senior Director
Seminars:
Bispecific Antibody Combinations for Optimized Anti-Tumor Activity in Liquid & Solid Tumors 3:45 pm
Co-localizing “signal 1” (TCR) and “signal 2” (co-stimulation) within the tumor microenvironment to drive optimized anti-tumor responses Integrating signal 3 (cytokine support) for even deeper anti-tumor responses Preclinical and clinical data support rational combinations with biologics in patientsRead more
day: Day 1